Restricted Specificity of Anti-V3 Antibodies Induced in Humans by HIV Candidate Vaccines-Reference-Cited by-同舟云学术

Restricted Specificity of Anti-V3 Antibodies Induced in Humans by HIV Candidate Vaccines

Published:1997-11-20 Issue:17 Volume:13 Page:1471-1485
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

COËFFIER ELIANE,EXCLER JEAN-LOUIS,KIENY MARIE PAULE,MEIGNIER BERNARD,MOSTE CATHERINE,TARTAGLIA JAMES,PIALOUX GILLES,SALMON-CÉRON DOMINIQUE,LECLERC CLAUDE

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.1997.13.1471

Reference38 articles.

1. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

2. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

3. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

4. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1

5. Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity;Virology;2008-11

2. Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients;AIDS;2006-02-14

3. Induced Fit in HIV-Neutralizing Antibody Complexes: Evidence for Alternative Conformations of the gp120 V3 Loop and the Molecular Basis for Broad Neutralization,;Biochemistry;2005-04-19

4. AIDS VACCINE: STATE OF THE ART AT THE BEGINNING OF THE THIRD MILLENNIUM;International Reviews of Immunology;2004-01

5. Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers;AIDS;2001-07